% | $
Quotes you view appear here for quick access.

Advaxis, Inc. Message Board

  • ahkydildock ahkydildock Mar 20, 2014 8:56 AM Flag

    Good News .... but .... how good?

    Ok, so the canine deal comes through; have to be glad for that. But ... look at the numbers:

    "Under the agreement, Aratana made a one-time upfront payment to Advaxis of $1 million and an additional $1.5 million equity investment in Advaxis common stock and warrants. Aratana agreed to pay up to an additional $6 million in clinical and regulatory milestones for each of the four products, assuming approvals in both cats and dogs in both United States and the European Union. In addition, Aratana agreed to pay up to $28.5 million in commercial milestones. Upon regulatory approval and commercialization of the immunotherapies, Aratana agreed to pay Advaxis a tiered royalty ranging from mid-single digit to 10% on net sales."

    This is not the stuff of financial transformation.
    And Aratana? Again, not the big name one would have hoped for.

    This looks like a deal that could be made, not one that should be made.

    I've been in and out of ADXS for years now. I want to believe, but keeps getting harder.
    Help me understand that this is more than just a deal; that it is a BIG deal.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
8.34+0.16(+1.96%)Jul 29 4:00 PMEDT